» Articles » PMID: 37215243

Searching for the Source: Extraovarian Primary Peritoneal Carcinoma Presenting As Chest Wall Masses

Overview
Publisher Elsevier
Date 2023 May 22
PMID 37215243
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Extraovarian primary peritoneal carcinoma (EOPPC) is a rare form of epithelial adenocarcinoma arising from the peritoneal lining with little to no ovarian involvement. To date, very few cases of EOPPC with primary tumors outside of the peritoneum have been described, the majority of which present with a primary tumor in the retroperitoneum. No cases have been reported with primary presentation as a chest wall mass.

Case Report: This case describes a 64-year-old woman referred for the evaluation of PAX8 positive chest wall masses. Biopsies of these masses demonstrated tumor architecture that was predominantly micropapillary with rare psammomatous calcifications. Immunohistochemically, the tumor was PAX8, CK7, ER, MOC31, and BerEP4 positive, with a mutational pattern of p53. This was consistent with Mullerian adenocarcinoma markers and suggestive of high-grade serous carcinoma. The patient was diagnosed with a unique presentation of EOPPC and is currently alive at 36 months post initial diagnosis. She has been treated with a combination of diagnostic surgery, chemotherapy and radiation therapy.

Conclusion: To the best of our knowledge, this is the first documented case of EOPPC presenting with a primary tumor of the chest wall. This case highlights the importance of pathology, immunohistology, and interdisciplinary collaboration in diagnosing and treating rare malignancies.

References
1.
Bloss J, Liao S, Buller R, Manetta A, Berman M, McMeekin S . Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol. 1993; 50(3):347-51. DOI: 10.1006/gyno.1993.1223. View

2.
McCluggage W, Wilkinson N . Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathology. 2005; 47(3):231-47. DOI: 10.1111/j.1365-2559.2005.02194.x. View

3.
Goodman M, Shvetsov Y . Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004. Cancer Epidemiol Biomarkers Prev. 2009; 18(1):132-9. PMC: 2706690. DOI: 10.1158/1055-9965.EPI-08-0771. View

4.
Mendonca J, Acharya V, Dsouza S, Sahu K, Kamath S, Kini J . In pursuit of the primary. Breathe (Sheff). 2022; 17(4):210142. PMC: 8919789. DOI: 10.1183/20734735.0142-2021. View

5.
Greco F, Pavlidis N . Treatment for patients with unknown primary carcinoma and unfavorable prognostic factors. Semin Oncol. 2009; 36(1):65-74. DOI: 10.1053/j.seminoncol.2008.10.005. View